Perrigo to acquire French OTC company HRA Pharma for $2.1bn
Perrigo Company plc has agreed to acquire Héra SAS (HRA Pharma), a French consumer self-care company, from funds affiliated with Astorg and Goldman Sachs Asset ... Read More
BirchBioMed reports breakthrough phase 2 trial results for FS2 in treating keloid scars
BirchBioMed, a Canadian clinical-stage immunology company, has unveiled promising results from a phase 2 trial of FS2, its pioneering antifibrotic therapy designed to treat keloid ... Read More